Colombia performed its first pediatric liver autotransplant on March 27, 2026, at the Hospital Infantil San Vicente Fundación in Medellín, operating on María Isabel Taborda Bernal, a 13-year-old girl whose liver tumor occupied 80% of the organ and compromised the vascular structures to the point where conventional surgery could not safely remove it. Three days after the 10-hour procedure, she was walking; by early May 2026, she had returned home.
The case drew national attention not only because of the patient’s age but because the procedure, a living-donor national first for Colombia, required an institutional capacity that very few medical centers in Latin America currently hold.
A procedure built around the patient’s own organ
A liver autotransplant, technically known as ex vivo liver resection and autotransplantation (ELRA), differs from a conventional transplant in one critical respect: Surgeons remove the patient’s own liver, operate on it outside the body to extract the tumor with precision impossible inside a living patient, and then reimplant the cleaned healthy tissue, which eliminates the need for a donor organ and removes the risk of rejection that accompanies all standard transplants.
The procedure demands that a single institution simultaneously house the expertise of surgical oncology, transplant surgery, hepatology, anesthesiology, and intensive care pediatrics, disciplines that in Colombia operate at that combined level in only a handful of centers.
Jaime Alberto Ramírez, the transplant surgeon who coordinated the intervention at Hospital Infantil San Vicente Fundación, described the planning process as “very rigorous” and involving more than 30 specialists across multiple weeks of preparation, adding that “being able to do it safely is only possible when an institution manages to integrate oncological and transplant surgery at this level of development.”
The quote captures precisely why the procedure carried national significance: It demonstrated not just a single surgeon’s skill but a systemic institutional capability that Colombia built over the years.
Colombia’s transplant system is the foundation
That achievement rests on a national transplant infrastructure that Colombia has expanded steadily since Law 1805 of 2016 established presumed consent for organ donation, shifting the country’s donor pool and allowing institutions to grow their surgical volumes.
Colombia performed 1,247 solid organ transplants in 2024, according to the Instituto Nacional de Salud (INS), placing it among the highest-volume systems in the region, with Medellín and Bogota concentrating the most complex procedures. Yet pediatric access to high-complexity surgery remains clustered in a handful of urban centers, creating significant obstacles for rural patients with similar diagnoses.
Worth noting, the Hospital Infantil San Vicente Fundación is a private non-profit pediatric referral center with a consolidated liver transplant program; its capacity to execute this procedure reflects decades of institutional investment rather than a single exceptional event, which is why the surgical team framed the announcement as a program milestone rather than an isolated case.
What the Medellin case signals for Colombian medicine
The own-liver national first that Medellín registered in March 2026 carries implications beyond the individual patient’s recovery, since it places Colombia in a small group of countries whose pediatric surgical programs have reached the technical threshold required for ex vivo liver procedures, a threshold that most health systems in the region have not crossed.
That positioning matters for medical training, for international referral networks, and for the credibility of Colombia’s claim to regional leadership in high-complexity healthcare.
The country’s greatest challenge lies in the gap between Colombia’s top centers and everyday access, and Medellin’s autotransplant makes that divide impossible to ignore.